Health Strategies Group

Health Strategies Group

Research-based sales and marketing intelligence to the pharmaceutical and biotech industry. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD98—146m (Dealroom.co estimates Mar 2009.)
United States (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout
N/A

$17.9m

Seed

N/A

Acquisition
Total FundingCAD24.4m

Recent News about Health Strategies Group

Edit
More about Health Strategies Groupinfo icon
Edit

HealthStrategies.com, operating under the EVERSANA brand, is a leading independent provider of integrated commercial services to the life sciences industry. The company focuses on delivering patient-centered, value-based care solutions that span the entire product life cycle, from launch readiness to in-market products. HealthStrategies.com serves pharmaceutical, biotechnology, and medical device companies, helping them navigate complex commercial challenges and optimize their market performance. The business model revolves around offering a comprehensive suite of services, including clinical trial recruitment, patient support, nursing services, and strategic consulting. Revenue is generated through service contracts with life sciences companies, leveraging a global network of over 3,000 team members to deliver measurable value for clients and their patients.

Keywords: integrated services, life sciences, patient-centered care, value-based care, clinical trial recruitment, patient support, nursing services, strategic consulting, pharmaceutical, biotechnology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.